About Bilberry Pharmaceuticals Private Limited
Data last updated:
Bilberry Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24299MP2016PTC041803. Its GSTIN is 23AAHCB0160E1ZD (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Devendra Kumar Pathak and Roshni Pathak.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Green Velly Flat No.C – 507 Kanadiya Road, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.62 Cr, a growth of 67% compared to the previous year. For the same year it recorded a net profit of ₹3.33 Lakh (net margin 0.5%) and EBITDA of ₹23.94 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 58% over three years and 46% over five years.
The company has about 21 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Bilberry Pharmaceuticals. As per MCA filings, the company has open charges of ₹1.35 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bilberry.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressGreen Velly Flat No.C – 507 Kanadiya Road, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bilberry Pharmaceuticals Private Limited
The main business activity of Bilberry Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bilberry Pharmaceuticals Private Limited FY 2025 filings available
Bilberry Pharmaceuticals Private Limited reported revenue of ₹6.62 Cr (up 67% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Bilberry Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 46% over five years, including 67% growth in the latest year. EBITDA rose 93% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Bilberry Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹23.94 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.33 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Bilberry Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bilberry Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Bilberry Pharmaceuticals Private Limited
Bilberry Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sorbax Pharmaceuticals Private Limited | ₹6.71 Cr (FY 2025) | •••• | •••• | -16.0% | •••• | Baddi, Himachal Pradesh, India |
| TPPL Pharmaceuticals Private Limited | ₹6.69 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Jaipur, Rajasthan, India |
| Experts Pharmaceuticals Private Limited | ₹6.67 Cr (FY 2025) | •••• | •••• | -30.0% | •••• | Ahmedabad, Gujarat, India |
| Ostrich Pharmaceuticals Private Limited | ₹6.63 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | New Delhi, Delhi, India |
| Shree Radhey Gobind Pharmaceuticals Private Limited | ₹6.63 Cr (FY 2025) | •••• | •••• | -27.0% | •••• | Delhi, India |
| Bilberry Pharmaceuticals Private Limited this company | ₹6.62 Cr (FY 2024) | •••• | •••• | 67.0% | •••• | Indore, Madhya Pradesh, India |
| Moksh Pharmaceuticals Private Limited | ₹6.56 Cr (FY 2022) | •••• | •••• | 89.0% | •••• | Vadodara, Gujarat, India |
| Vernear Chemicals & Pharmaceuticals Private Limited | ₹6.55 Cr (FY 2025) | •••• | •••• | 168.0% | •••• | Tijara, Rajasthan, India |
| Alwin Willcure Pharmaceuticals Private Limited | ₹6.52 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | New Delhi, Delhi, India |
| Genesia Pharmaceuticals (India) Private Limited | ₹6.51 Cr (FY 2024) | •••• | •••• | 23.0% | •••• | Jaipur, Rajasthan, India |
| Grahams Pharmaceuticals Private Limited | ₹6.5 Cr (FY 2024) | •••• | •••• | -12.0% | •••• | Kochi, Kerala, India |
Peers are the five companies nearest above and the five nearest below Bilberry Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Bilberry Pharmaceuticals Private Limited
Bilberry Pharmaceuticals Private Limited is audited by ABV & Company for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ABV & Company | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Bilberry Pharmaceuticals Private Limited
Bilberry Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devendra Kumar Pathak | Director | 08 Nov 2016 | 9 Years 11 Months | Current |
| Roshni Pathak Also directs: Master's Summit Foundation | Director | 17 Nov 2016 | 9 Years 10 Months | Current |
Ownership and Shareholding of Bilberry Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Bilberry Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jan 2024 | Tata Capital Housing Finance Limited | ₹1.35 Cr | Open |
Total charge records: 1 View all charges
Associated Brands with Bilberry Pharmaceuticals Private Limited
Bilberry Pharmaceuticals operates one associated brand: Bilberry Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provision of quality ethical drugs and pharmaceuticals with a focus on assurance systems. | bilberry.in |
Employees and EPFO Compliance at Bilberry Pharmaceuticals Private Limited
Bilberry Pharmaceuticals Private Limited has a workforce of 21 employees as of Mar 29, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bilberry Pharmaceuticals Private Limited
Bilberry Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Roshni Pathak ceased to be Additional Director on 20 Dec 2017.
Credit Ratings, Litigation & Regulatory Alerts for Bilberry Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bilberry Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bilberry Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bilberry Pharmaceuticals Private Limited
Bilberry Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAHCB0160E1ZD | Madhya Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bilberry Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bilberry Pharmaceuticals Private Limited
Bilberry Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 November 2016 (10+ years old) and is registered under CIN U24299MP2016PTC041803.
Bilberry Pharmaceuticals reported revenue of ₹6.62 Cr for FY 2024 (up 67% YoY).
Bilberry Pharmaceuticals has 2 current directors:
- Devendra Kumar Pathak - Director
- Roshni Pathak - Director
Bilberry Pharmaceuticals reported a net profit of ₹3.33 Lakh (net margin 0.5%) and EBITDA of ₹23.94 Lakh (EBITDA margin 3.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Bilberry Pharmaceuticals is 58% over three years and 46% over five years. In the latest year (FY 2024) revenue rose 67%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Bilberry Pharmaceuticals is 23AAHCB0160E1ZD, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Bilberry Pharmaceuticals is U24299MP2016PTC041803. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bilberry Pharmaceuticals was incorporated on 08 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Bilberry Pharmaceuticals by revenue are Sorbax Pharmaceuticals Private Limited, TPPL Pharmaceuticals Private Limited, Experts Pharmaceuticals Private Limited, Ostrich Pharmaceuticals Private Limited, Shree Radhey Gobind Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Roshni Pathak ceased to be Additional Director on 20 Dec 2017. Amod Kumar Singh ceased to be Director on 17 Nov 2016. Roshni Pathak was appointed as Director on 17 Nov 2016. Bilberry Pharmaceuticals has 4 board changes on record in total.
Bilberry Pharmaceuticals can be reached through the website bilberry.in. Its registered office is in Indore, Madhya Pradesh, India.